SCNI

Scinai Immunotherapeutics
SCNI

Overview Fund Trends Analyst Outlook Journalist POV

14 hedge funds and large institutions have $389K invested in Scinai Immunotherapeutics in 2022 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 3 increasing their positions, 4 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

less ownership

Funds ownership: →

less funds holding

Funds holding: →

less repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

less capital invested

Capital invested by funds: $ → $

80% less first-time investments, than exits

New positions opened: 1 | Existing positions closed: 5

Holders
14
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$133K
2
+$21K
3
+$6.92K
4
APC
Aspire Private Capital
North Carolina
+$1K

Top Sellers

1
-$52.9K
2
-$38K
3
-$34K
4
Citadel Advisors
Citadel Advisors
Florida
-$21.6K
5
Morgan Stanley
Morgan Stanley
New York
-$16.7K
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$191K
2
$64K
3
$39K
4
$28K
5
$21K
6
$16K
7
$13K
8
$5K
9
$5K
10
$3K
11
$2K
12
$1K
13
$1K
14
–
15
–
16
–
17
–
18
–